Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.
Colombel JF, Sandborn WJ, Reinisch W, Peyrin-Biroulet L, Panaccione R, Rutgeerts P, Hanauer SB, Ghosh S, Van Assche G, Robinson AM, Lau W, Maa JF, Huang B, Pappalardo B, Read H.
Colombel JF, et al.
Aliment Pharmacol Ther. 2018 Jan;47(2):219-228. doi: 10.1111/apt.14420. Epub 2017 Nov 21.
Aliment Pharmacol Ther. 2018.
PMID: 29159817